Aptevo Therapeutics APVO
NASDAQ APVO
$1.77 +0.01 (+0.57%)
As of: Oct 2, 2026 · 12:12 PM EDT

Aptevo Therapeutics (APVO) Accumulated Expenses (2024 - 2026)

Updated

Aptevo Therapeutics' Accumulated Expenses was $3.11 million in Q2 2026, up 4.4% from the prior quarter.

Analysis

Aptevo Therapeutics (APVO) Accumulated Expenses (2024 - 2026) Analysis & Trends

At the end of FY2025, Accumulated Expenses at Aptevo Therapeutics came in at $4.31 million, up 2.6% from FY2024.

  • In earlier years, Accumulated Expenses was $4.2 million in FY2024.
  • Quarterly Accumulated Expenses has moved between $2.98 million (Q1 2026) and $4.31 million (Q4 2025) over five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Aptevo Therapeutics 2.58 Mn -64.42 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.11 Mn
Mar 31, 2026 2.98 Mn
Dec 31, 2025 4.31 Mn
Dec 31, 2024 4.20 Mn
API Access

Aptevo Therapeutics Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=APVO&period=max&api_key=YOUR_API_KEY